The Effects and Mechanisms of Traditional Chinese Medicine and Extracts on Stem Cells and the Application of Stem Cells to Treat Disease: A Review.
Fang Y., Yu X., Feng Z., Qin F., Zheng Z., Zhu Y.
Clinical Trial on Diabetic Foot, Stroke Research, Chronic Inflammation, Immune Modulation, published in Curr Pharm Des (2026) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Clinical Trial
- Journal
- Curr Pharm Des (2026)
- Country
- United Arab Emirates
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41832681
- DOI
- 10.2174/0113816128436713251216113058
Abstract (original English)
This review examines the synergistic effects and mechanisms of Traditional Chinese Medicine (TCM) and its extracts on mesenchymal stem cells (MSCs), with a focus on enhancing MSC proliferation, differentiation, and immunomodulation for therapeutic applications. A comprehensive analysis of studies from the past five years was conducted, evaluating interactions between TCM/extracts and MSC types (bone marrow-, adipose-, and umbilical cord-derived MSCs) through molecular pathways (e.g., PI3K/Akt, Wnt/β- catenin, TGF-β/Smad) and microRNA regulation. In vitro, in vivo, and clinical trial data were synthesized. TCM and extracts significantly upregulated osteogenic/adipogenic differentiation in bone marrow mesenchymal stem cells via miR-335-5p/PTEN and Runx2 pathways, enhanced the viability of adipose-derived mesenchymal stem cells under oxidative stress via Sirt1/Akt activation, and improved the immunomodulation of umbilical cord mesenchymal stem cells by increasing anti-inflammatory factors (HGF, PGE2). Combined MSC-TCM therapies accelerated diabetic ulcer healing (via the miR-146A-NF-κB axis), reduced liver fibrosis (via miR-19b-3p), and mitigated stroke/arthritis symptoms. TCM synergizes with MSCs through multipathway crosstalk and miRNA regulation, amplifying therapeutic efficacy in degenerative, inflammatory, and ischemic diseases. Clinical translation requires standardized TCM
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations